Product NDC: | 59630-700 |
Proprietary Name: | Orapred |
Non Proprietary Name: | prednisolone sodium phosphate |
Active Ingredient(s): | 10 mg/1 & nbsp; prednisolone sodium phosphate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59630-700 |
Labeler Name: | Shionogi Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021959 |
Marketing Category: | NDA |
Start Marketing Date: | 20060601 |
Package NDC: | 59630-700-48 |
Package Description: | 8 BLISTER PACK in 1 CARTON (59630-700-48) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
NDC Code | 59630-700-48 |
Proprietary Name | Orapred |
Package Description | 8 BLISTER PACK in 1 CARTON (59630-700-48) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Product NDC | 59630-700 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | prednisolone sodium phosphate |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20060601 |
Marketing Category Name | NDA |
Labeler Name | Shionogi Inc. |
Substance Name | PREDNISOLONE SODIUM PHOSPHATE |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |